InVivo Therapeutics Corp Beta
Quel est le Beta de InVivo Therapeutics Corp?
Le Beta de InVivo Therapeutics Holdings Corp est 1.07
Quelle est la définition de Beta?
BETA indique si une action est plus ou moins volatile que le marché dans son ensemble. Un bêta inférieur à 1 indique que l'action est moins volatile que le marché, tandis qu'un bêta supérieur à 1 indique que l'action est plus volatile. La volatilité est mesurée par la fluctuation du prix autour de la moyenne.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta des entreprises dans Health Care secteur sur NASDAQ par rapport à InVivo Therapeutics Corp
Que fait InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Entreprises avec beta similaire à InVivo Therapeutics Corp
- Nitto Denko a Beta de 1.07
- Minerals Technologies a Beta de 1.07
- Asia Orient a Beta de 1.07
- China Aerospace International a Beta de 1.07
- Umang Dairies a Beta de 1.07
- Umicore a Beta de 1.07
- InVivo Therapeutics Corp a Beta de 1.07
- Playgon Games a Beta de 1.07
- First Merchants a Beta de 1.07
- Audinate a Beta de 1.07
- Funtastic a Beta de 1.07
- Canasil Resources a Beta de 1.07
- Wuxi Biologics (Cayman) a Beta de 1.07